No image

cobas SARS-CoV-2

09408592190 · Roche Molecular Systems, Inc.

Details

Device typeSARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT): A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of nucleic acid from severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) in a clinical specimen, using a nucleic acid technique (NAT). This test is used to aid the diagnosis of coronavirus disease (COVID-19) infection.

FDA categorySimple point-of-care device to detect SAR-CoV-2 nucleic acid targets from clinical specimens in near-patient settings

Device ID00875197006742

Catalog number09408592190

AvailabilityPrescription

Single useYes

MRI safetyLabeling does not contain MRI Safety Information

Contact

No contact is listed for this device.

Related products

Product	Model	Company	Device type
cobas SARS-CoV-2 Quality Control KitRoche Molecular Systems, Inc.SARS-CoV-2 nucleic acid IVD, control	09408835190	Roche Molecular Systems, Inc.	SARS-CoV-2 nucleic acid IVD, control
cobas® SARS-CoV-2 Qualitative Control KitRoche Molecular Systems, Inc.SARS-CoV-2 nucleic acid IVD, control	09446117190	Roche Molecular Systems, Inc.	SARS-CoV-2 nucleic acid IVD, control
Aptima®Hologic, Inc.SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)	BOX 1, REFRIG, SARS-COV-2 ASSAY, APTIMA 100T, IVD	Hologic, Inc.	SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
ID NOW COVID-19 2.0Alere Scarborough, Inc.SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)	192-000	Alere Scarborough, Inc.	SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)